SynthesisDiabetes, obesity & metabolism2018
Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.
Motoshi Ouchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled ittrialcites it